Jakafi 15 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FKKH4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,247
Award facts
- Contract value 100% obligated
- $12,246.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,246.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order, issued without set-aside designation, is scheduled for completion by December 22, 2025, and represents one of numerous pharmaceutical supply orders DMS has received from the Defense Logistics Agency's Medical Supply Chain division. The award leverages DMS Pharmaceutical Group's established capabilities as a critical supplier within the federal pharmaceutical distribution network.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency designated as SPE2DR, which was awarded on November 13, 2025, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent IDC carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, positioning DMS as a regional prime vendor contractor within the $30.3 billion PPV-G GEN V acquisition strategy. Through this master contract structure, DMS supplies a comprehensive range of pharmaceuticals, biologics, and medical consumables to support Department of Defense healthcare operations globally, with firm fixed-price delivery orders issued to fulfill recurring medical supply needs across military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FKKH4?
SPE2DR26FKKH4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FKKH4 worth?
The government has obligated $12,247 on SPE2DR26FKKH4.
Is contract SPE2DR26FKKH4 an order under another contract?
Yes. SPE2DR26FKKH4 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKH4 competed?
The extent of competition for SPE2DR26FKKH4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award